GoodRx Holdings, Inc. (GDRX) vs Kardigan, Inc. (KARD)
A side-by-side comparison of GoodRx Holdings, Inc. and Kardigan, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
GDRX
GoodRx Holdings, Inc.
$3.33HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
KARD
Kardigan, Inc.
$12.85HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — GDRX vs KARD
growth of $100 · dividends reinvested · last 1yGDRX +26.3% (+26.3%/yr)KARD -30.7% (-30.7%/yr)GDRX compounded faster over this window
GDRX KARD
GDRX vs KARD: by the numbers
- •GDRX is the larger company ($1.16B vs $1.15B market cap).
- •GDRX is profitable (2.07% net margin) while KARD runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | GDRX | KARD |
|---|---|---|
| P/E ratio | 78.42 | N/A |
| P/S ratio | 1.47 | N/A |
| P/B ratio | 1.78 | 1.87 |
| EV / EBITDA | 8.27 | N/A |
| FCF yield | 12.62% | N/A |
Profitability
| Metric | GDRX | KARD |
|---|---|---|
| Gross margin | 88.05% | 0.00% |
| Operating margin | 10.25% | 0.00% |
| Net margin | 2.07% | 0.00% |
| ROE | 2.51% | N/A |
| ROIC | 3.72% | -57.11% |
Growth (annualized)
| Metric | GDRX | KARD |
|---|---|---|
| Revenue CAGR (5Y) | 4.47% | N/A |
| FCF CAGR (5Y) | 11.72% | N/A |
| Total return CAGR (5Y) | -39.98% | N/A |
Frequently asked
- Is GDRX or KARD more profitable?
- GDRX runs the higher net margin — GDRX at 2.07% versus KARD at 0.00%.
Go deeper
Dig into the metrics
GoodRx P/E ratioGoodRx ROEKardigan ROEGoodRx operating marginKardigan operating marginGoodRx revenue growthKardigan revenue growthGoodRx free cash flowKardigan free cash flow
GoodRx & Kardigan appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.